The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Correlations between epicardial flow, microvascular reperfusion, infarct size and clinical outcomes in patients with anterior versus non-anterior myocardial infarction treated with primary or rescue angioplasty: analysis from the EMERALD trial
Eugenia Nikolsky1*, MD, PhD, FACC; Gregg W. Stone1, MD, FACC; Edwin Lee1, MD; Alexandra J. Lansky1, MD, FACC; John Webb2, MD; David A. Cox3, MD, FACC; Bruce R. Brodie4, MD, FACC; Mark A. Turco5, MD, FACC; Barry D. Rutherford6, MD, FACC; Anna M. Kalynych7, MD, FACC; David Antoniucci8, MD; Mitchell W. Krucoff9, MD, FACC; Raymond J. Gibbons9, MD, FACC; Martin Fahy1, MSc; Roxana Mehran1, MD, FACC
1. Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY, USA; 2. St Paul’s Hospital, Vancouver, British Columbia, Canada; 3. Lehigh Valley Hospital, Allentown, PA, USA; 4. Moses Cone Hospital, Greensboro, NC, USA; 5.
Aims: We compared epicardial and microvascular reperfusion, infarct size, and clinical outcomes after primary and rescue PCI with and without GuardWire distal protection in patients with LA